Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neovastat (AE-941) in Refractory and Early Relapse Multiple Myeloma Patients

NCT00022282 is registered in ClinicalTrials.gov with AEterna Zentaris as lead sponsor.

NCT NCT00022282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00022282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neovastat (AE-941) in Refractory and Early Relapse Multiple Myeloma Patients
Lead sponsor
AEterna Zentaris
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2001
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma and plasma cell neoplasm